IDEAS home Printed from https://ideas.repec.org/a/kap/jtecht/v32y2007i4p397-423.html
   My bibliography  Save this article

Technology transfer perspectives in globalising India (drugs and pharmaceuticals and biotechnology)

Author

Listed:
  • S. Agarwal
  • Ashwani Gupta
  • R. Dayal

Abstract

The paper briefly outlines the status of technology transfer related issues in drugs & pharma and biotechnology sectors in India. The paper also outlines the contemporary business strategies including R&D and technology transfer models. The study indicates that present technology transfer policies and mechanisms are weak and need to be restructured. The current fiscal incentives and tax concessions etc. available for R&D in industry seem to have outlived and are no longer attractive because of continuous lowering of tariff rates and tax rates in the context of WTO and liberalization of policies. Moreover, the issue of R&D support to industry is not covered in the WTO as in case of subsidies. Therefore, it is advisable for the government to revisit the existing promotional measures for R&D. FDI policies also need to be tailored to encourage Technology transfers and capability building. Recommendations are made for making Technology Transfer more effective for the growth and competitiveness of the industry. A technology transfer management model is suggested. Copyright Springer Science+Business Media, LLC 2007

Suggested Citation

  • S. Agarwal & Ashwani Gupta & R. Dayal, 2007. "Technology transfer perspectives in globalising India (drugs and pharmaceuticals and biotechnology)," The Journal of Technology Transfer, Springer, vol. 32(4), pages 397-423, August.
    • Handle: RePEc:kap:jtecht:v:32:y:2007:i:4:p:397-423
    DOI: 10.1007/s10961-006-9025-8
    as

    Download full text from publisher

    File URL: http://hdl.handle.net/10.1007/s10961-006-9025-8
    Download Restriction: Access to full text is restricted to subscribers.
    File URL: https://libkey.io/10.1007/s10961-006-9025-8?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Schmiele, Anja, 2009. "Drivers for international innovation activities in developed and emerging countries," ZEW Discussion Papers 09-064, ZEW - Leibniz Centre for European Economic Research.
    2. Fonseca, Elize Massard da & Shadlen, Kenneth C. & Achcar, Helena de Moraes, 2023. "Vaccine technology transfer in a global health crisis: Actors, capabilities, and institutions," Research Policy, Elsevier, vol. 52(4).
    3. Helena Lenihan & Kevin Mulligan & Justin Doran & Christian Rammer & Olubunmi Ipinnaiye, 2024. "R&D grants and R&D tax credits to foreign-owned subsidiaries: Does supporting multinational enterprises’ R&D pay off in terms of firm performance improvements for the host economy?," The Journal of Technology Transfer, Springer, vol. 49(2), pages 740-781, April.
    4. Basant, Rakesh & Srinivasan, Shuchi, 2015. "Intellectual Property Protection in India and Implications for Health Innovation: Emerging Perspectives," IIMA Working Papers WP2015-04-01, Indian Institute of Management Ahmedabad, Research and Publication Department.
    5. Anja Schmiele, 2012. "Drivers for international innovation activities in developed and emerging countries," The Journal of Technology Transfer, Springer, vol. 37(1), pages 98-123, February.
    6. Bhawani Bhatnagar & Viktor Dörfler & Jillian MacBryde, 2023. "Navigating the open innovation paradox: an integrative framework for adopting open innovation in pharmaceutical R&D in developing countries," The Journal of Technology Transfer, Springer, vol. 48(6), pages 2204-2248, December.

    More about this item

    Keywords

    Technology; R&D; Drugs & pharma; Biotechnology; Competitiveness; Policy; WTO; Incentives; Globalization; Model; Technology transfer; O33;
    All these keywords.

    JEL classification:

    • O33 - Economic Development, Innovation, Technological Change, and Growth - - Innovation; Research and Development; Technological Change; Intellectual Property Rights - - - Technological Change: Choices and Consequences; Diffusion Processes

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:kap:jtecht:v:32:y:2007:i:4:p:397-423. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.